Long term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial - Schneider, T; Abdulrahman, R; Corssmit, E P (Eur J Endocrinol, 2012)
[Epub ahead of print]